Orchestra Biomed Holdings, Inc. (OBIO)
5.08
+0.34
(+7.17%)
USD |
NASDAQ |
Sep 04, 16:00
5.07
-0.01
(-0.20%)
After-Hours: 20:00
Orchestra Biomed Holdings Research and Development Expense (Quarterly) : 16.59M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.59M |
| March 31, 2026 | 15.78M |
| December 31, 2025 | 16.82M |
| September 30, 2025 | 14.03M |
| June 30, 2025 | 13.85M |
| March 31, 2025 | 13.48M |
| December 31, 2024 | 10.97M |
| September 30, 2024 | 11.60M |
| June 30, 2024 | 11.13M |
| Date | Value |
|---|---|
| March 31, 2024 | 9.112M |
| December 31, 2023 | 8.511M |
| September 30, 2023 | 8.558M |
| June 30, 2023 | 8.499M |
| March 31, 2023 | 8.254M |
| December 31, 2022 | 7.543M |
| September 30, 2022 | 5.899M |
| June 30, 2022 | 5.029M |
| March 31, 2022 | 3.474M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |
| Rockwell Medical, Inc. | 0.04M |